Alternatively, in ZR-75 human breast cancer cells shRNA-mediated survivin knock-down was evaluated using a commercially available plasmid that permitted selecting populations expressing shRNA against survivin or a scrambled shRNA sequence. The gene discussed is BIRC5; the disease is breast carcinoma.